Solid Biosciences (SLDB) Return on Equity: 2018-2024
Historic Return on Equity for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to -0.57%.
- Solid Biosciences' Return on Equity rose 14.00% to -0.57% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.57%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.57% for FY2023, which is 8.00% down from last year.
- Latest data reveals that Solid Biosciences reported Return on Equity of -0.57% as of Q3 2024, which was down 26.44% from -0.45% recorded in Q2 2024.
- Solid Biosciences' Return on Equity's 5-year high stood at -0.45% during Q2 2024, with a 5-year trough of -3.14% in Q3 2020.
- Over the past 3 years, Solid Biosciences' median Return on Equity value was -0.57% (recorded in 2024), while the average stood at -0.58%.
- Its Return on Equity has fluctuated over the past 5 years, first slumped by 198bps in 2020, then grew by 17bps in 2024.
- Quarterly analysis of 4 years shows Solid Biosciences' Return on Equity stood at -1.14% in 2020, then reached -0.56% in 2022, then fell by 15bps to -0.72% in 2023, then climbed by 14bps to -0.57% in 2024.
- Its last three reported values are -0.57% in Q3 2024, -0.45% for Q2 2024, and -0.54% during Q1 2024.